Back to Search
FRANCIS BUI, PHARM.D
PHARM.D
Pharmacist
NPI: 1578042131Individual
Specialties, Licenses & Credentials
PharmacistPrimary
Pharmacist
Code: 183500000X
78569(CA)
Research & Publications (20)
Volterra series modelling and compensation of non-linear distortions caused by susceptibility difference artefacts related to the presence of ferromagnetic implants in magnetic resonance imaging.
PMID 11410386·Med Eng Phys·2001
8-other
Presurgical (99m)Tc-sestamibi brain SPET/CT versus SPET: a comparison with MRI and histological data in 33 patients with brain tumours.
PMID 19561554·Nucl Med Commun·2009
4-observational
Usefulness of combined sestamibi scintimammography, axillary ultrasonography and FNA cytology in reducing the number of sentinel node procedures in patients with early-stage breast cancer.
PMID 19331192·Anticancer Res·2009
8-other
Structurally colored thiol chitosan thin films as a platform for aqueous heavy metal ion detection.
PMID 18067263·Biomacromolecules·2008
8-other
Thyroid C-cell hyperplasia shown by combined In-111 pentetreotide, Tc-99m pertechnetate, and Tc-99m MIBI scintigraphy.
PMID 17452867·Clin Nucl Med·2007
5-case
Accuracy of ultrasonography and 99mTc-sestamibi scintimammography for assessing axillary lymph node status in breast cancer patients. A prospective study.
PMID 16797155·Eur J Surg Oncol·2006
8-other
Sensitivity and positive predictive value of CT, MRI and 123I-MIBG scintigraphy in localizing pheochromocytomas: a prospective study.
PMID 16794519·Nucl Med Commun·2006
2-rct
A meta-iodobenzylguanidine scintigraphic scoring system increases accuracy in the diagnostic management of pheochromocytoma.
PMID 16728579·Endocr Relat Cancer·2006
4-observational
Relationship between prognostic factors of breast cancer and 99mTc-sestamibi uptake in patients who underwent scintimammography: Multivariate analysis of causes of false-negative results.
PMID 15985369·Breast·2006
3-trial
Technetium-99m sestamibi scintigraphy and helical CT together in patients with primary hyperparathyroidism: a prospective clinical study.
PMID 15010380·Br J Radiol·2004
3-trial
Hyperfunctioning parathyroid tumours in patients with thyroid nodules. Sensitivity and positive predictive value of high-resolution ultrasonography and 99mTc-sestamibi scintigraphy.
PMID 14503919·Endocr Relat Cancer·2003
4-observational
[Changes in esophageal peristalsis in diverse clinical forms and antibody specificity in scleroderma: a scintigraphic study in 100 cases].
PMID 12874641·Reumatismo·2003
4-observational
Non-invasive adrenal imaging in primary aldosteronism. Sensitivity and positive predictive value of radiocholesterol scintigraphy, CT scan and MRI.
PMID 12766605·Nucl Med Commun·2003
3-trial
Positive predictive value of 99mTc sestamibi scintimammography in patients with non-palpable, mammographically detected, suspicious, breast lesions.
PMID 12411835·Nucl Med Commun·2002
3-trial
Usefulness of CT scan, MRI and radiocholesterol scintigraphy for adrenal imaging in Cushing's syndrome.
PMID 11973488·Nucl Med Commun·2002
4-observational
Accuracy of technetium-99m sestamibi scintimammography and X-ray mammography in premenopausal women with suspected breast cancer.
PMID 11734915·Eur J Nucl Med·2001
8-other
Scintigraphic patterns of adrenocortical carcinoma: morpho-functional correlates.
PMID 11720899·Eur J Endocrinol·2001
8-other
Usefulness of 99m-Tc-sestamibi scintimammography in suspected breast cancer and in axillary lymph node metastases detection.
PMID 11373101·Eur J Surg Oncol·2001
3-trial
Angiotensin converting enzyme inhibition worsens the excretory phase of diuretic renography for obstructive hydronephrosis.
PMID 11371966·J Urol·2001
8-other
Advantages of combined technetium-99m-sestamibi scintigraphy and high-resolution ultrasonography in parathyroid localization: comparative study in 91 patients with primary hyperparathyroidism.
PMID 11124858·Eur J Endocrinol·2000
4-observational
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 101 G ST
SAN DIEGO, CA 92101 - Phone
- (619) 237-7660
Quick Facts
- NPI
- 1578042131
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile